Dopamine agonist withdrawal syndrome in a patient with restless legs syndrome

被引：11
|
作者：
Dorfman, Benjamin J. [1 ]
Nirenberg, Melissa J. [1 ]
机构：
[1] Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY USA
来源：
PARKINSONISM & RELATED DISORDERS | 2013年 / 19卷 / 02期
关键词：
Dopamine agonist withdrawal syndrome; Impulse control disorder; Dopamine agonist; Restless legs syndrome; Dopamine dysregulation syndrome; PARKINSON DISEASE;
D O I：
10.1016/j.parkreldis.2012.06.006
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：269 / 270
页数：2
相关论文
共 50 条
  • [31] Increased Synaptic Dopamine in the Putamen in Restless Legs Syndrome
    Earley, Christopher J.
    Kuwabara, Hiroto
    Wong, Dean F.
    Gamaldo, Charlene
    Salas, Rachel E.
    Brasic, James R.
    Ravert, Hayden T.
    Dannals, Robert F.
    Allen, Richard P.
    SLEEP, 2013, 36 (01) : 51 - 57
  • [32] Safety of Dopamine Agonists for Treating Restless Legs Syndrome
    Weiss, Howard D.
    MOVEMENT DISORDERS, 2019, 34 (01) : 150 - 150
  • [33] Efficacy and safety of dopamine agonists in restless legs syndrome
    Hornyak, Magdolna
    Trenkwalder, Claudia
    Kohnen, Ralf
    Scholz, Hanna
    SLEEP MEDICINE, 2012, 13 (03) : 228 - 236
  • [34] The Emergence of Devastating Impulse Control Disorders During Dopamine Agonist Therapy of the Restless Legs Syndrome
    Dang, Dien
    Cunnington, David
    Swieca, John
    CLINICAL NEUROPHARMACOLOGY, 2011, 34 (02) : 66 - 70
  • [35] Another dopamine agonist for treatment of restless legs syndrome (vol 10, pg 675, 2011)
    Earley, C. J.
    LANCET NEUROLOGY, 2011, 10 (08): : 680 - 680
  • [36] A polysomnographic analysis of sex-related differences in dopamine agonist response in restless legs syndrome
    Mogavero, Maria Paola
    Antelmi, Elena
    Lanza, Giuseppe
    Marelli, Sara
    Castelnuovo, Alessandra
    Tinazzi, Michele
    Delrosso, Lourdes M.
    Ferri, Raffaele
    Ferini-Strambi, Luigi
    JOURNAL OF SLEEP RESEARCH, 2024, 33
  • [37] High national rates of high-dose dopamine agonist prescribing for restless legs syndrome
    Winkelman, John W.
    SLEEP, 2022, 45 (02)
  • [38] Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis
    Evans, Andrew H.
    MOVEMENT DISORDERS, 2007, 22 (04) : 590 - 591
  • [39] APLINDORE, A PARTIAL DOPAMINE AGONIST, REDUCES PERIODIC LIMB MOVEMENTS IN PATIENTS WITH RESTLESS LEGS SYNDROME
    Mayleben, D.
    Safirstein, B.
    Rajachandran, L.
    Dorffner, G.
    Allen, R. P.
    Anerio, L.
    Sprenger, K.
    Stankovic, S.
    SLEEP, 2009, 32 : A304 - A304
  • [40] Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample
    Allen, Richard P.
    Ondo, William G.
    Ball, Eric
    Calloway, Michael O.
    Manjunath, Ranjani
    Higbie, Rachel L.
    Lee, Mechele R.
    Nisbet, Paul A.
    SLEEP MEDICINE, 2011, 12 (05) : 431 - 439
12345